-
Which Pharma Players Dominate The Lung Cancer Space?
Wednesday, January 25, 2017 - 3:40pm | 946Read More...Lung and bronchus cancer is the leading cause of cancer deaths in the United States, according to the National Cancer Institute. Lung cancer is of two types, namely non-small cell lung cancer, or NSCLC and small cell lung cancer, or SCLC, with the former more prevalent than the latter. Estimates by...
-
Clovis Oncology Plummets After Rociletinib Approval Rejected
Tuesday, April 12, 2016 - 4:25pm | 139Read More...Shares of Clovis Oncology Inc (NASDAQ: CLVS) fell more than 5 percent on Tuesday. The company announced the U.S. Food and Drug Administration Oncologic Drugs Advisory Committee (ODAC) met to discuss approval of the New Drug Application for Rociletinib. Shares of Clovis Oncology closed Monday...
-
Clovis Oncology Falls 8%: Here's What You Need To Know
Friday, April 8, 2016 - 2:11pm | 320Read More...Shares of Clovis Oncology Inc (NASDAQ: CLVS) lost more than 8 percent on Friday after the company confirmed that the FDA posted briefing documents ahead of the Oncologic Drugs Advisory Committee (ODAC) meeting to discuss accelerated approval of the New Drug Application (NDA) for rociletinib. The...
-
Clovis Oncology Issues Update On Rociletinib, Will Meet With FDA On April 12
Friday, February 12, 2016 - 12:09pm | 189Read More...Clovis Oncology Inc (NASDAQ: CLVS) announced on Friday that the U.S. Food and Drug Administration has scheduled a date of April 12, 2016 to discuss a New Drug Application for its rociletinib therapy. Rociletinib is an investigational therapy for the treatment of patients with mutant epidermal...
-
Clovis Oncology Plunges 70% In One Morning: What Happened?
Monday, November 16, 2015 - 12:00pm | 507Read More...Shares of Clovis Oncology Inc (NASDAQ: CLVS) plunged more than 70 percent on Monday, establishing a new multi-year low of $26.05. Shares of Clovis were initially halted early Monday morning as the company reported that the FDA submitted a request for additional information on the company...
-
16 Biotech Stocks Moving Off The ASCO Conference
Monday, June 1, 2015 - 3:51pm | 578Read More...The ASCO (American Society of Clinical Oncology) is hosting its annual meeting, and the healthcare world is watching very attentively. In this event, cancer and cancer-related drug developers share results from some recent drug trials and, to a certain degree, mark the path that will be traversed...
